Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

NASDAQ:CROX - Nasdaq - US2270461096 - Common Stock - Currency: USD

106.74  -0.39 (-0.36%)

After market: 106.74 0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CROX. CROX was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CROX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make CROX suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
CROX had positive earnings in each of the past 5 years.
Each year in the past 5 years CROX had a positive operating cash flow.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 18.90%, CROX belongs to the top of the industry, outperforming 93.75% of the companies in the same industry.
CROX has a better Return On Equity (48.63%) than 95.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 21.12%, CROX belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 11.45%.
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROIC 21.12%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX has a better Profit Margin (23.35%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
With an excellent Operating Margin value of 24.84%, CROX belongs to the best of the industry, outperforming 97.92% of the companies in the same industry.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 59.25% is fine compared to the rest of the industry. CROX outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.75 indicates that CROX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.75, CROX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CROX has a debt to FCF ratio of 1.68. This is a very positive value and a sign of high solvency as it would only need 1.68 years to pay back of all of its debts.
CROX has a Debt to FCF ratio of 1.68. This is in the better half of the industry: CROX outperforms 79.17% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that CROX is somewhat dependend on debt financing.
CROX has a worse Debt to Equity ratio (0.75) than 66.67% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Altman-Z 3.75
ROIC/WACC2.41
WACC8.75%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.52 indicates that CROX should not have too much problems paying its short term obligations.
CROX has a Current ratio of 1.52. This is in the lower half of the industry: CROX underperforms 75.00% of its industry peers.
CROX has a Quick Ratio of 1.52. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, CROX is doing worse than 62.50% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.55% over the past year.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.64% yearly.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 2.09% in the last year.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 27.23% on average per year.
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 2.29% on average per year.
EPS Next Y-1.91%
EPS Next 2Y0.92%
EPS Next 3Y-1.1%
EPS Next 5Y2.84%
Revenue Next Year1.71%
Revenue Next 2Y2.33%
Revenue Next 3Y1.73%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.13 indicates a reasonable valuation of CROX.
CROX's Price/Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 85.42% of the companies in the same industry.
When comparing the Price/Earnings ratio of CROX to the average of the S&P500 Index (27.28), we can say CROX is valued rather cheaply.
CROX is valuated cheaply with a Price/Forward Earnings ratio of 7.97.
Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CROX is valued rather cheaply.
Industry RankSector Rank
PE 8.13
Fwd PE 7.97
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than CROX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaply inside the industry as 85.42% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.77
EV/EBITDA 6.71
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y0.92%
EPS Next 3Y-1.1%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (7/2/2025, 5:35:45 PM)

After market: 106.74 0 (0%)

106.74

-0.39 (-0.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners101.51%
Inst Owner Change2.15%
Ins Owners2.49%
Ins Owner Change5.65%
Market Cap5.98B
Analysts81.82
Price Target129.76 (21.57%)
Short Float %11.87%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.88%
Min EPS beat(2)9.31%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)12.98%
Min EPS beat(4)9.31%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)14.09%
EPS beat(12)12
Avg EPS beat(12)14.76%
EPS beat(16)16
Avg EPS beat(16)17.35%
Revenue beat(2)2
Avg Revenue beat(2)1.05%
Min Revenue beat(2)0.88%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)1.22%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)7
Avg Revenue beat(12)0.52%
Revenue beat(16)10
Avg Revenue beat(16)1.27%
PT rev (1m)4.67%
PT rev (3m)-1.57%
EPS NQ rev (1m)-0.32%
EPS NQ rev (3m)1.43%
EPS NY rev (1m)-1.58%
EPS NY rev (3m)-2.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 8.13
Fwd PE 7.97
P/S 1.46
P/FCF 6.77
P/OCF 6.28
P/B 3.04
P/tB N/A
EV/EBITDA 6.71
EPS(TTM)13.13
EY12.3%
EPS(NY)13.39
Fwd EY12.55%
FCF(TTM)15.76
FCFY14.77%
OCF(TTM)16.99
OCFY15.92%
SpS73.14
BVpS35.13
TBVpS-9.18
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 18.9%
ROE 48.63%
ROCE 23.35%
ROIC 21.12%
ROICexc 21.96%
ROICexgc 53.87%
OM 24.84%
PM (TTM) 23.35%
GM 59.25%
FCFM 21.55%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 1.68
Debt/EBITDA 1.36
Cap/Depr 95.51%
Cap/Sales 1.68%
Interest Coverage 11.16
Cash Conversion 87.36%
Profit Quality 92.29%
Current Ratio 1.52
Quick Ratio 0.97
Altman-Z 3.75
F-Score6
WACC8.75%
ROIC/WACC2.41
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.55%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-0.66%
EPS Next Y-1.91%
EPS Next 2Y0.92%
EPS Next 3Y-1.1%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.09%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-0.14%
Revenue Next Year1.71%
Revenue Next 2Y2.33%
Revenue Next 3Y1.73%
Revenue Next 5Y2.29%
EBIT growth 1Y-4.07%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-0.47%
EBIT Next 3Y-3.04%
EBIT Next 5Y3.43%
FCF growth 1Y53.79%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y39.75%
OCF growth 3Y20.5%
OCF growth 5Y61.62%